Home ETF List About

ETF Holdings Breakdown of SOLV

Stock NameSolventum Corp.
TickerSOLV(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS83444M1018

SOLV institutional holdings

The following institutional investment holdings of SOLV have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-11 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 352,119USD 26,014,552 2.8% 73.88  
2025-11-11 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 352,119USD 26,014,552 2.8% 73.88  
2025-11-11 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 352,119USD 26,014,552 2.8% 73.88  
2025-11-11 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 208,456USD 15,400,729 2.8% 73.88  
2025-11-11 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 208,456USD 15,400,729 2.8% 73.88  
2025-11-11 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 208,456USD 15,400,729 2.8% 73.88  
2025-11-11 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 208,456USD 15,400,729 2.8% 73.88  
2025-11-11 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 51,928 -0.1%USD 3,836,441 2.8% 73.88  
2025-11-11 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 37,325 0.1%USD 2,757,571 7.2% 73.88  
2025-11-11 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 45,642USD 3,372,031 2.8% 73.88  
2025-11-11 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 45,642USD 3,372,031 2.8% 73.88  
2025-11-11 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 45,642USD 3,372,031 2.8% 73.88  
2025-11-11 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 14,518 -0.4%USD 1,072,590 2.4% 73.88  
2025-11-11 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 26,436USD 1,684,426 2.4% 63.72  
2025-11-11 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 8,550USD 631,674 2.8% 73.88  
2025-11-11 IE00BP3QZB59 (iShares Edge MSCI World Value Factor UCITS ETF) 27,730 -1.1%USD 2,048,692 1.7% 73.88  
2025-11-11 IE00BFYTYS33 (iShares Edge MSCI World Value Factor UCITS USD Dist) 27,730 -1.1%USD 2,048,692 1.7% 73.88  
2025-11-07 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 11,721USD 838,286 7.3% 71.52  
2025-11-11 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 107,091 -0.1%USD 7,911,883 2.8% 73.88  
2025-11-11 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 107,091 -0.1%USD 7,911,883 2.8% 73.88  
2025-11-11 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 8,774 -1.0%USD 559,054 2.0% 63.72  
2025-11-11 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 72,943USD 5,389,029 2.8% 73.88  
2025-11-11 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 72,943USD 5,389,029 2.8% 73.88  
2025-11-11 IE00BD1F4M44 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP) 31,365USD 2,317,246 2.8% 73.88  
2025-11-11 IE00BFF5RX68 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)) 31,365USD 2,317,246 2.8% 73.88  
2025-11-11 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 6,174USD 456,135 2.8% 73.88  
2025-11-11 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 2,726USD 201,397 10.3% 73.88  
2025-11-11 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 3,747USD 276,828 2.8% 73.88  
2025-11-11 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 3,747USD 276,828 2.8% 73.88  
2025-11-10 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 3,179USD 173,571 0.4% 54.60  
2025-11-11 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 837USD 61,838 2.8% 73.88  
2025-11-11 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 837USD 61,838 2.8% 73.88  
2025-11-11 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 1,203USD 67,452 2.6% 56.07  
2025-11-11 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 6,065USD 448,082 2.8% 73.88  
2025-11-11 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 12,532USD 925,864 2.8% 73.88  
2025-11-11 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 1,337USD 98,778 2.8% 73.88  
2025-11-11 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 52,451USD 3,875,080 2.8% 73.88  
2025-11-10 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 37,325USD 2,679,562 0.4% 71.79  
2025-11-10 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 8,550 0.6%USD 613,805 8.2% 71.79  
2025-11-11 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 11,721USD 865,947 2.8% 73.88  
Total =2,817,048 USD 207,559,412
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with SOLV

Wells Fargo & Company Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price
Solventum (NYSE:SOLV – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from $79.00 to $82.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of […] - 2025-09-17 03:06:58
Solventum Completes Sale Of Purification & Filtration Business; Raises Annual Earnings Outlook
(RTTNews) - Solventum Corporation (SOLV) Tuesday said that it has completed the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. (TMO) for $4 billion in cash. - 2025-09-02 10:10:37
Solventum (NYSE:SOLV) Rating Increased to Strong-Buy at Wall Street Zen
Solventum (NYSE:SOLV – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Monday. Several other equities research analysts have also issued reports on SOLV. KeyCorp started coverage on Solventum in a report on Friday, June 6th. They set a […] - 2025-09-01 03:10:44
Solventum (NYSE:SOLV) Stock Rating Lowered by Wall Street Zen
Solventum (NYSE:SOLV – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. A number of other brokerages have also recently commented on SOLV. Morgan Stanley upgraded shares of Solventum from an “equal weight” rating to […] - 2025-08-24 06:14:43
Solventum Corporation (NYSE:SOLV) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lessened its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 18.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,479 shares of the company’s stock after selling 1,439 shares during the quarter. Maryland State Retirement […] - 2025-08-15 04:51:01
Solventum Announces Pricing Of Secondary Offering Of 8.80 Mln Common Stock
(RTTNews) - Solventum Corp. (SOLV) announced the pricing of the secondary offering of 8.80 million shares of its common stock, which is expected to result in gross proceeds of about $648 million to 3M Company. All of the shares of common stock are being sold by the Selling Shareh - 2025-08-14 00:33:56
Solventum Corporation (NYSE:SOLV) Shares Purchased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,173,960 shares of the company’s stock after buying an additional 24,762 shares during the quarter. Charles Schwab Investment Management […] - 2025-08-13 05:10:47
Blair William & Co. IL Sells 552 Shares of Solventum Corporation (NYSE:SOLV)
Blair William & Co. IL lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 4.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 11,010 shares of the company’s stock after selling 552 shares during the period. Blair William & Co. IL’s holdings in Solventum were worth $837,000 at […] - 2025-08-11 06:24:58
Federated Hermes Inc. Trims Position in Solventum Corporation (NYSE:SOLV)
Federated Hermes Inc. trimmed its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 67.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 764 shares of the company’s stock after selling 1,595 shares during the quarter. Federated Hermes Inc.’s holdings in Solventum were worth $58,000 as of its most recent filing with […] - 2025-08-11 05:04:58
Solventum (NYSE:SOLV) Price Target Raised to $94.00
Solventum (NYSE:SOLV – Free Report) had its price objective upped by Piper Sandler from $87.00 to $94.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts also recently weighed in on the company. Morgan Stanley raised Solventum from […] - 2025-08-11 03:08:46
XTX Topco Ltd Grows Stock Position in Solventum Corporation (NYSE:SOLV)
XTX Topco Ltd lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 26.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,417 shares of the company’s stock after purchasing an additional 1,356 shares during the quarter. XTX Topco Ltd’s […] - 2025-08-08 04:38:55
Noteworthy Thursday Option Activity: AKAM, EXPE, SOLV
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Akamai Technologies Inc (Symbol: AKAM), where a total of 8,566 contracts have traded so far, representing approximately 856,600 underlying shares. That amounts to about 5 - 2025-08-07 14:17:28
Financial Analysis: Solventum (NYSE:SOLV) and BG Medicine (OTCMKTS:BGMD)
BG Medicine (OTCMKTS:BGMD – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Valuation & Earnings This table compares BG Medicine and […] - 2025-08-05 02:41:00
Solventum Corporation (NYSE:SOLV) Receives $84.38 Average Target Price from Brokerages
Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have earned an average rating of “Hold” from the eleven brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-08-01 02:50:51
Universal Beteiligungs und Servicegesellschaft mbH Buys 584 Shares of Solventum Corporation (NYSE:SOLV)
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 1.1% during the 1st quarter, Holdings Channel reports. The firm owned 53,143 shares of the company’s stock after purchasing an additional 584 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Solventum were worth $4,041,000 at the […] - 2025-07-29 05:22:58
7,059 Shares in Solventum Corporation (NYSE:SOLV) Purchased by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new stake in Solventum Corporation (NYSE:SOLV – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 7,059 shares of the company’s stock, valued at approximately $537,000. Several other institutional investors have also added to or reduced their stakes […] - 2025-07-28 06:02:51
New York State Common Retirement Fund Reduces Holdings in Solventum Corporation (NYSE:SOLV)
New York State Common Retirement Fund lowered its position in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 24.1% during the first quarter, Holdings Channel reports. The fund owned 67,549 shares of the company’s stock after selling 21,500 shares during the quarter. New York State Common Retirement Fund’s holdings in Solventum were worth $5,136,000 […] - 2025-07-22 07:09:10
Solventum Corporation (NYSE:SOLV) Shares Sold by Cwm LLC
Cwm LLC cut its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 13.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,875 shares of the company’s stock after selling 2,420 shares during the period. Cwm LLC’s holdings in Solventum […] - 2025-07-21 05:18:49
Cerity Partners LLC Buys 1,294 Shares of Solventum Corporation (NYSE:SOLV)
Cerity Partners LLC grew its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 2.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,466 shares of the company’s stock after buying an additional 1,294 shares during the quarter. Cerity Partners […] - 2025-07-18 04:55:04
Solventum Corporation (NYSE:SOLV) Shares Sold by Arizona State Retirement System
Arizona State Retirement System trimmed its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 0.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,466 shares of the company’s stock after selling 173 shares during the period. Arizona […] - 2025-07-17 05:51:11
Morgan Stanley Upgrades Solventum (NYSE:SOLV) to Overweight
Solventum (NYSE:SOLV – Get Free Report) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research report issued on Tuesday, Marketbeat.com reports. The brokerage presently has a $103.00 target price on the stock, up from their prior target price of $80.00. Morgan Stanley’s price target […] - 2025-07-17 05:00:52
Solventum Corporation (NYSE:SOLV) Shares Sold by Stratos Wealth Partners LTD.
Stratos Wealth Partners LTD. lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 50.6% in the 1st quarter, Holdings Channel reports. The firm owned 4,256 shares of the company’s stock after selling 4,355 shares during the period. Stratos Wealth Partners LTD.’s holdings in Solventum were worth $324,000 at the end of […] - 2025-07-16 04:58:53
Solventum Corporation (NYSE:SOLV) Shares Sold by D.A. Davidson & CO.
D.A. Davidson & CO. lowered its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 11.8% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,478 shares of the company’s stock after selling 1,002 shares during the period. D.A. Davidson & CO.’s holdings in Solventum were worth […] - 2025-07-11 05:26:54
Solventum Corporation (NYSE:SOLV) Receives $81.50 Average Price Target from Analysts
Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to […] - 2025-07-07 02:06:56
Solventum Corporation (NYSE:SOLV) Position Lessened by Cambridge Investment Research Advisors Inc.
Cambridge Investment Research Advisors Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 4.5% during the 1st quarter, HoldingsChannel reports. The firm owned 18,893 shares of the company’s stock after selling 895 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Solventum were worth $1,437,000 as of its most recent […] - 2025-07-04 04:32:51
Sumitomo Mitsui Trust Group Inc. Sells 586 Shares of Solventum Corporation (NYSE:SOLV)
Sumitomo Mitsui Trust Group Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 0.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 319,689 shares of the company’s stock after selling 586 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Solventum were worth $24,309,000 at the end of […] - 2025-07-03 05:35:09
Robeco Institutional Asset Management B.V. Purchases 2,544 Shares of Solventum Corporation (NYSE:SOLV)
Robeco Institutional Asset Management B.V. lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 8.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 31,238 shares of the company’s stock after purchasing an additional 2,544 shares during the quarter. Robeco Institutional Asset Management […] - 2025-07-02 06:14:53
Mirae Asset Global Investments Co. Ltd. Decreases Position in Solventum Corporation (NYSE:SOLV)
Mirae Asset Global Investments Co. Ltd. cut its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 5.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,617 shares of the company’s stock after selling 3,174 shares […] - 2025-07-02 05:35:01
Perigon Wealth Management LLC Acquires 159 Shares of Solventum Corporation (NYSE:SOLV)
Perigon Wealth Management LLC raised its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 3.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,352 shares of the company’s stock after acquiring an additional 159 shares during the quarter. Perigon Wealth […] - 2025-07-01 05:09:18
Solventum Corporation (NYSE:SOLV) Shares Purchased by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC increased its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 137.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,344 shares of the company’s stock after purchasing an additional 10,027 shares during the quarter. […] - 2025-06-30 06:10:48

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.